Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults

Size: px
Start display at page:

Download "Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults"

Transcription

1 1101 Nephrol Dial Transplant (2012) 27: doi: /ndt/gfr430 Advance Access publication 29 July 2011 Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults Nazrul Jafry 1, Ejaz Ahmed 1, Muhammed Mubarak 2, Javed Kazi 2 and Fazal Akhter 1 1 Department of Nephrology, Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan and 2 Department of Histopathology, SIUT, Karachi, Pakistan Correspondence and offprint requests to: Muhammed Mubarak; info@siut.org Abstract Background. There is no information in international literature on the mode of presentation, laboratory and clinical features, treatment and prognosis of primary focal segmental glomerulosclerosis (FSGS) in adults in Pakistan. Methods. This is a retrospective review of 124 adults (17 years) with a diagnosis of primary FSGS who presented to the adult nephrology clinic at Sindh Institute of Urology and Transplantation between January 1995 and June The clinical records and biopsy reports were reviewed to determine the demographic, clinical, laboratory and pathologic features, treatment responses and outcome of the disease. Renal biopsies were performed and evaluated by light microscopy, immunofluorescence and electron microscopy. Standard therapeutic regimens and response to therapy definitions were used. Outcome data were obtained at last follow-up. Results. Mean age of all patients was years (range: years). Of these, 86 (69%) were males and 38 (31%) females, with a male to female ratio of 2.2:1. Of 124 patients, 79 (63.7%) were treated with steroids for a median duration of 5 months. Remission was achieved in 40 (50.6%) patients. Relapse occurred in 14 (17.7%) steroid-treated patients. These achieved sustained remission with retreatment. None of the steroid-treated patients went into end-stage renal disease over a mean follow-up of 2.3 years. Conclusions. Results from this study show that half of adults with primary FSGS achieve sustained remission with prolonged steroid treatment and consequently exhibit an excellent prognosis for long-term outcome. Moreover, raised serum creatinine at presentation does not in itself adversely affect steroid response in adults with primary FSGS. Keywords: adults; focal segmental glomerulosclerosis; nephrotic syndrome; renal biopsies; Pakistan Introduction Primary focal segmental glomerulosclerosis (FSGS) is a clinicopathologic syndrome in which variable amounts of proteinuria, usually of nephrotic range, are associated with the renal biopsy finding of focal and segmental scarring of the glomeruli [1 4]. First described by Rich in 1957 in an autopsy series, it has now become the leading cause of idiopathic nephrotic syndrome (INS) in adult populations worldwide [1, 5 7]. The clinical course of patients with primary FSGS is one of the progressive renal insufficiency leading to end-stage renal disease (ESRD) >5 10 years in >50% of cases [8 12]. It is currently the most common primary glomerulonephritis in theusathatleadstoesrdinbothadultsandchildren [11]. Hence, its accurate diagnosis has considerable therapeutic and prognostic implications. We have earlier reported FSGS as the leading cause of INS in adults in Pakistan [13]. Ó The Author Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please journals.permissions@oup.com

2 1102 N. Jafry et al. Although the natural course of primary FSGS has been well described, its treatment is still a matter of debate [14 28]. Although steroids constitute the mainstay of treatment, primary FSGS in adults has historically been regarded as a steroid-resistant disease. However, more recent studies using high-dose steroids for prolonged periods have produced promising results [15 28]. Detailed clinicopathologic analysis of primary FSGS in adults, particularly its treatment and prognosis, has not been reported from Pakistan in international literature to date. In this study, we report our single-center experience on the clinical presentation, laboratory features, response to treatment, clinical course and long-term prognosis in adults with primary FSGS. Materials and methods This is a retrospective review of 124 consecutive adults (17 years) with a biopsy diagnosis of idiopathic or primary FSGS who presented to the adult nephrology clinic of Sindh Institute of Urology and Transplantation between January 1995 and June 2006 with at least 6 months of regular follow-up. Patients with known secondary causes of FSGS, including systemic diseases with glomerular involvement, acquired immunodeficiency syndrome, intravenous heroin abuse, solitary kidney and urinary obstruction and/or reflux, were excluded from the study. The original biopsy reports and clinical records were reviewed to determine the patients age, sex, level of protein excretion, presence of hypertension, serum creatinine, total protein and serum albumin and presence of hematuria. All patients underwent percutaneous native renal biopsies under real-time ultrasound guidance. Informed consent was obtained from patients prior to undertaking the biopsy. Renal biopsy specimens were examined jointly by two experienced renal pathologists and classified according to standard criteria [2]. Nephrotic syndrome (NS) was diagnosed in accordance with standard guidelines [13]. Hypertension was defined as blood pressure (BP) readings exceeding 150 mmhg for systolic BP and 90 mmhg for diastolic BP in two consecutive measurements in the supine position or the need for antihypertensive therapy. Elevated serum creatinine was defined as serum creatinine value of >1.4 mg/dl in males and >1.2 mg/dl in females. ESRD was defined as the permanent need for renal replacement therapy [11]. Standard therapeutic regimen and response to therapy definitions with slight modifications were used [14 19, 22, 23]. Briefly, the patients were treated with 1.0 mg prednisone/kg body weight per day for 6 weeks, followed by 0.75 mg/kg/day of prednisone for six additional weeks, which was then gradually tapered >3 months. Complete remission was defined as a decrease in the rate of urinary protein excretion to at least 0.2 g/day for at least 1 month, with plasma creatinine persistently <1.5 mg/dl. Partial remission was defined as a decrease in the rate of urinary protein excretion to between 0.21 and 2 g/day for at least 1 month, with plasma creatinine <1.5 mg/dl [19]. Time to remission was calculated from the date of first treatment to the date of remission [22]. Relapse was defined as recurrence of the nephrotic range proteinuria and edema while tapering the dose of steroids or on stopping steroid treatment. Relapsers received a second course of steroid treatment alone or in combination with cyclophosphamide. The persistent doubling of serum creatinine over baseline values was used as a surrogate marker for progressive renal insufficiency [19]. The clinical course and outcome of each patient were evaluated by recording current medications, BP, serum creatinine and albumin levels, urinalysis and 24-h urinary protein excretion. Pathologic study At our center, two cores of native renal tissue are routinely obtained for complete pathologic evaluation by light microscopy (LM), immunofluorescence (IF) and electron microscopy (EM) as described in detail in our previous study [13]. The pathological diagnosis was taken from the original biopsy reports in our histopathology record and was not formally reexamined by the pathologists. Light microscopy (LM) For LM, routinely 10 serial sections are cut with Levels 1, 5 and 10 stained by hematoxylin and eosin, Level 7 is stained with trichrome, Level 8 by periodic acid-schiff and Level 9 by Jones methenamine silver stain. FSGS was diagnosed according to established criteria by two experienced renal pathologists first independently and then jointly to arrive at a consensus diagnosis [2]. Immunofluorescence (IF) Tissue specimens for IF were stained by the direct method using fluorescein isothiocyanate-conjugated antisera monospecific for IgG, IgA, IgM, C3 and C1q (Dako, Glostrup, Denmark) as detailed in our earlier report [13]. IF findings on the biopsy specimens were obtained from the original biopsy reports. Electron microscopy (EM) Tissue samples for EM were processed according to a presently established technique [13]. Briefly, EM tissue was fixed in 4% glutaraldehyde, post-fixed in 1% osmium tetroxide at 0.02 M Sorenson Phosphate buffer at ph 7.4, processed for EM and embedded in Eponate resin. Ultra-thin sections (100 nm) were cut on Leica ultramicrotome. Sections were stained on copper 300-mesh girds with Uranyl acetate and Lead citrate and examined with a JEM 1200 EX II electron microscope. EM study was performed in all cases and the EM findings were obtained from the original biopsy reports. Statistical tests Statistical analysis was carried out using IBM-compatible SPSS for Windows version 10 (SPSS, Chicago, IL). Simple descriptive statistics such as mean SD and median (interquartile range) were used for continuous variables such as age and clinical and laboratory parameters. Numbers (%) were used for categorical data. For comparisons of various parameters among the groups, Student s t-test and chi-square tests were used. Pearson s correlation was used to find a relationship, if any, between the elevated serum creatinine and the other clinical and laboratory findings at the time of presentation. A P-value of <0.05 was considered significant. Results Patients demographic, clinical and laboratory features on presentation The patient characteristics at the time of presentation are shown in Table 1. A total of 124 patients satisfied study criteria and were entered into the study. Of these, 86 (69%) were males and 38 (31%) were females, with a male to female ratio of 2.2:1. The mean age was years with a range of years. The mean 24-h urinary protein excretion was g/day [median: 4.7 ( )]. Of 124 patients, 72% had nephrotic-range proteinuria, with 24% having heavy proteinuria, defined as protein excretion of >8 g/day. Mean serum albumin was g/dl (median: 2.0 g/dl). The mean serum creatinine was mg/100 ml (median: 1.1 mg/100 ml). An elevated serum creatinine was found at presentation in 42 (33.8%) patients; among these, 32 (37.2%) were males and 10 (26.3%) were females. Pearson s correlation testing of elevated serum creatinine on presentation showed a poor and non-significant correlation of this parameter with the duration of disease (r ¼ 0.11, P ¼ 0.47), systolic BP (r ¼ 0.26, P ¼ 0.94), diastolic BP (r ¼ 0.22, P ¼ 0.15), serum albumin (r ¼ 0.15, P ¼ 0.42), initial proteinuria (r ¼ 0.13, P ¼ 0.41), antihypertensive treatment (r ¼ 0.17, P ¼ 0.28) and

3 Primary FSGS in adults in Pakistan 1103 Table 1. Patient demographic, clinical and laboratory findings at presentation and at last follow-up in all patients with primary FSGS a Age (in years) Mean 6 SD (range) (17 85) Median (IQR) 26 (20 38) Sex Male 86 (69%) Female 38 (31%) Male to female ratio 2.2:1 Duration of symptoms (in weeks) Mean 6 SD Median (IQR) 26 (8 57) Systolic BP (mmhg) Mean 6 SD Median (IQR) 130 ( ) Diastolic BP (mmhg) Mean 6 SD Median (IQR) 90 (80 100) Initial proteinuria (mg/24 h) Mean 6 SD Median (IQR) 4695 ( ) Serum albumin (g/dl) Mean 6 SD Median (IQR) 2.0 ( ) Serum creatinine (mg/dl) Mean 6 SD Median (IQR) 1.1 ( ) Elevated serum creatinine [n (%)] Male (>1.4 mg/dl) 32 (37.2%) Female (>1.2 mg/dl) 10 (26.3%) Final proteinuria (mg/24 h) Mean 6 SD Median (IQR) 3344 ( ) Follow-up duration (weeks) Mean 6 SD Median (IQR) 64 (32 156) a IQR, interquartile range. the number of antihypertensive drugs (r ¼ 0.02, P ¼ 0.87). The mean systolic BP was mmhg and mean diastolic BP was mmhg. Treatment responses and follow-up Of all patients with primary FSGS, 79 (63.7%) were treated with doses of steroids as envisaged in our treatment protocol. The total dose, duration and response to steroid treatment are given in Table 2. Of 79 patients, 40 (50.6%) achieved remission with this regimen. Of these, 36 (45.5%) achieved complete remission, while 4 (5%) showed partial remission. The mean time to remission was weeks. It is of note that about half of the patients showed delayed response to steroids (>3 months) and the response continued for as long as 6 months in a few patients, as shown in Figure 1. Among initial responders, 14 (35%) patients relapsed after a mean duration of weeks (range: weeks). These patients were treated with a second course of steroids alone (11 patients: 78.6%) or steroids in combination with cyclophosphamide (3 patients: 21.4%). All 14 relapsers again achieved complete remission of proteinuria. All these patients were in remission till the end of this study. A comparison of some clinical, laboratory and treatment parameters between steroid-responsive and non-responder groups is shown in Table 3. This shows that steroid non-responder group had Table 2. The duration and dose of steroids and remission rates in 79 patients with primary FSGS who were treated with steroids at our center a Duration of steroid treatment (weeks) Mean 6 SD Median (IQR) 20.0 ( ) Total steroid dose (mg) Mean 6 SD Median (IQR) 4340 ( ) Steroid dose (mg/kg) Mean 6 SD Median (IQR) 74.2 ( ) Remission (n ¼ 40) Complete remission 36 (50.6%) Partial remission 04 (5%) Time to remission (in weeks) Mean 6 SD Median (IQR) 12.0 ( ) a IQR, interquartile range. Fig. 1. Time to remission in weeks in steroid-responsive patients with primary FSGS. more severe disease as reflected by higher levels of proteinuria and lower serum albumin levels and higher systolic BP at the time of presentation. A comparison of elevated serum creatinine among steroid-responsive and steroid non-responder groups on presentation and at last followup is shown in Table 4. An elevated serum creatinine on presentation was more common in the steroid-responsive group and on last follow-up in the steroid non-responder group (P < 0.05). An elevated serum creatinine was not considered in itself a contraindication to the treatment of these patients. In fact, a majority of these patients (29; 69%) were treated with steroids. An analysis of the clinical course in this subgroup of steroid-treated patients is shown in Table 5. It is apparent from this table that in these cases, serum creatinine either decreased or stabilized with steroid treatment and was most likely related to hemodynamic alterations rather than chronic renal damage. A poor correlation of this parameter with other presenting clinical and laboratory features also favors this hemodynamic origin. A comparison of some clinical and laboratory features between treated and untreated patients is shown in Table 6. It is evident that the untreated patients had less severe disease as shown by a higher serum albumin and lower level of proteinuria compared with treated patients, but there were some other reasons for not treating these patients. The mean follow-up duration for all patients was weeks (median: 64 weeks). A persistent doubling of serum creatinine over baseline values was observed in eight

4 1104 N. Jafry et al. Table 3. Comparison of clinical, laboratory and treatment parameters among steroid-responsive and -resistant primary FSGS groups Parameters Steroid-responsive group (n ¼ 40) Steroid-resistant group (n ¼ 39) P-value Age (years) (mean 6 SD) Sex (M:F) 28:12 25: Systolic BP (mmhg) a Diastolic BP (mmhg) Initial protein (mg/24 h) a Initial serum creatinine (mg/dl) Initial serum albumin (g/dl) Total steroid dose (mg) Steroid dose (mg/kg) Steroid duration (weeks) a Statistically significant. Table 4. Comparison of elevated serum creatinine at presentation and last follow-up among steroid-responsive and steroid-resistant FSGS groups Parameters Steroid-responsive group (n ¼ 40) Steroid-resistant group (n ¼ 39) P-value Duration of follow-up (in weeks) Elevated serum creatinine on presentation 18 (47.4%) 9 (24.3%) 0.03 a Elevated serum creatinine on last follow-up 5 (13.5%) 13 (36.1%) 0.02 a Doubling of serum creatinine 1 (2.5%) 7 (17.9%) a a Statistically significant Table 5. Clinical course of 29 patients with elevated serum creatinine who were treated with steroids Initial serum creatinine (mg/dl) Mean 6 SD (range) ( ) Median 2.0 Repeat serum creatinine after treatment (mg/dl) Mean 6 SD (range) ( ) Median 1.4 Duration of repeat serum creatinine (in weeks) Mean 6 SD (range) ( ) Median 12.6 Serum creatinine at last follow-up (mg/dl) Mean 6 SD (range) ( ) Median 1.37 Duration of last serum creatinine (in weeks) Mean 6 SD (range) ( ) Median 48.3 Table 6. Comparison of some clinical and laboratory parameters between steroid-treated and -untreated groups at our center Parameters Treated group (n ¼ 79) Non-treated group (n ¼ 45) P-value Age (in years) (mean 6 SD) Sex (M:F) 53:26 34: Initial proteinuria (mg/24 h) Initial serum albumin (g/dl) a Initial serum creatinine (mg/dl) Duration of follow-up (weeks) a Statistically significant. (20%) patients; seven (17. 5%) of these belonged to steroid non-responder group and one (2.5%) to steroid-responsive group. None of the treated patients went into ESRD till last follow-up. Discussion We herein present our experience in one of the largest case series of primary FSGS in adults with regard to clinical presentation, laboratory features, treatment responses and long-term outcome in Pakistan. We acknowledge that the study has certain limitations. These include the retrospective nature of the study, heterogeneity of the disease at presentation, relatively short follow-up and its origin from a single center. Although it is single-center-based study, the catchment area of our adult nephrology services extends more or less to the whole country. We provide all the consultation and medications free of cost, which ensures a fairly high rate of compliance and regular follow-up. Our patient population is homogenous with respect to racial origin. Uniform clinical and pathologic criteria for the

5 Primary FSGS in adults in Pakistan 1105 diagnosis of primary FSGS and its management have been used over the study period by the same nephrologists and the pathologists. Thus, we believe that our study results fairly accurately represent the clinical course and the outcome of this entity in adults from this country. The presenting clinical and laboratory features of this relatively young adult population of primary FSGS were not different from that described previously in literature [12, 14]. Almost, all patients (98%) had symptomatic edema despite varying degrees of proteinuria, which was sub-nephrotic in 28% subjects. It is well known that when serum albumin concentration is very low, albumin excretion in urine may fall to sub-nephrotic range [2 4]. In addition, there is mounting evidence that a significant portion of filtered albumin is taken up by proximal tubular epithelial cells and catabolized and measured protein excretion in urine underestimates the actual leakage [4]. This would lead to hypoalbuminemia without manifesting as nephrotic range proteinuria. Moreover, fluid retention in glomerular diseases may be disassociated with degree of proteinuria and serum albumin concentration [4]. The underrepresentation of asymptomatic patients in our study is most likely due to the infrequent referral of such patients or biopsy policy. The number of patients with elevated serum creatinine at presentation (42; 33.8%) is similar to most of the previously reported series [12, 14]. An elevated serum creatinine in these cases could be due to chronic and irreversible loss of renal function or may well be a reflection of homodynamic alterations in acute onset NS [12]. The fact that the majority of steroid-responsive patients with an elevated serum creatinine at presentation showed improvement or stabilization of renal function supports the latter mechanism in our patients. There was also a poor correlation of this parameter with other clinical or laboratory features at presentation, further supporting its hemodynamic origin and the reversibility. Since corticosteroids are the mainstay of treatment and the therapeutic response to steroids seems to be the best predictor of long-term outcome and prognosis, it is our policy to treat all eligible adults with primary FSGS with standard doses of steroids, if not otherwise contraindicated [17]. We were able to perform a detailed analysis of steroid response in 79 (63.7%) patients who received primary treatment at our center according to our protocol. It is worth mentioning here that in the current clinical practice, 40 50% of patients with FSGS and nephrotic-range proteinuria are not treated with immunosuppression [22]. The overall remission rate achieved in our steroid-treated cohort was 50.6%. The steroid response rates in different studies have varied from 30 to 67%, depending on the dose and duration of steroid treatment [22, 23]. Our treatment protocol consisted of daily high-dose steroid treatment for 3 months followed by tapering over next 2 3 months. This is shorter than the current recommendation of high-dose steroid treatment for 4 6 months [23]. A response rate as high as 80% has been reported in some series with protracted steroid treatment [22, 23]. However, steroid dose was not maintained at a high dose after 3 months in these studies. This suggests that steroids in a lower dose but for longer period after initial high dose do have remission-inducing effects. Steroid dosage in our study was usually reduced to 0.5 mg/ kg/day by the beginning of fourth month and the median duration of steroid treatment was 5 months. The fact that half of the patients responded after 3 months (Figure 1) also supports the phenomenon of delayed response to prolonged lower dose treatment. This may have important implications for future treatment as side effects of high-dose steroids are considerable, and if these observations are confirmed in prospectively conducted trials, it may decrease steroid-related morbidity. A lower baseline protein excretion and a lower systolic BP were associated with favorable response to steroid treatment in our cohort as shown in Table 3. It is generally assumed that patients with heavy proteinuria have more severe disease, which may not respond well to steroids [12, 14]. On the other hand, a lower protein excretion has not been consistently shown to be predictive of steroid response [23]. The clinical significance of lower systolic BP among responders is not known. The baseline serum creatinine was unexpectedly high among steroid-responsive group, although it did not reach statistical significance. An elevated creatinine at presentation is usually considered a poor prognostic marker in terms of subsequent renal survival and has also been shown to influence steroid response [14]. In one study providing a stratified analysis, remission was achieved in only 5 of 21(23.8%) patients with a serum creatinine exceeding 1.4 mg/dl compared to 36 of 60 (60%) with lower serum creatinine concentration [12]. In our study, elevated serum creatinine at presentation was not predictive of steroid responsiveness and we suggest that it should not deter the clinician from starting steroid treatment, especially in subjects with short duration of illness. The proportion of subjects with elevated creatinine at baseline was significantly higher in steroid-responsive group but decreased significantly after attaining a remission. Although the cumulative steroid dose in the steroid-resistant group was similar to the steroid-responsive group, the former received steroids for slightly shorter duration. This may reflect relatively rapid tapering in subjects responding poorly to steroid treatment after 3 months of high-dose therapy. Among responders, 14 (35%) patients relapsed after initial successful response; 11 of these were retreated with steroids alone and 3 with steroids in combination with cyclophosphamide. Both subgroups responded again with complete remission. There is paucity of data in adults regarding management of initially steroid-responsive patients, who later relapse [14]. We did not encounter frequent relapsers in our adult patients. Response to steroids is associated with long-term preservation of renal function in patients with FSGS [12, 14, 23]. Only one patient in the steroid-responsive group experienced a doubling of serum creatinine during follow-up and none developed ESRD. In a study of FSGS patients followed for a longer period, renal function was well preserved for up to 10 years in steroid-responsive patients, whereas steroid resistance was predictive of development of ESRD in 57% of cases within an average period of 6.5 years [12]. The fact that nearly 18% of our steroid-resistant cases have already doubled their serum creatinine after a mean follow-up of 2.3 years highlights the poor renal prognosis of this group of patients.

6 1106 N. Jafry et al. We did not observe any spontaneous remission in subjects who were not treated with steroids either at our center or elsewhere. Due to their relatively shorter follow-up which was erratic as well, they were not analyzed in detail. But, spontaneous remissions have been rare in previously reported series also ranging from 5 to 23% of primary FSGS in adults [22, 23]. In conclusion, results from this study show that half of adults with primary FSGS achieve sustained remission with steroids and consequently exhibit an excellent prognosis for long-term outcome. Moreover, a raised serum creatinine at presentation does not in itself adversely affect steroid response in adults with primary FSGS and may result from hemodynamic alterations rather than chronic irreversible renal damage. Conflict of interest statement. None declared. References 1. Rich AR. A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 1957; 100: D Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 1994; 46: Cameron JS. The enigma of focal segmental glomerulosclerosis. Kidney Int 1996; 50 (Suppl 57): S119 S Korbet SM. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 1998; 9: Haas M, Spargo BH, Coventry S. Increasing incidence of focal segmental glomerulosclerosis among adult nephropathies: a 20-years renal biopsy study. Am J Kidney Dis 1995; 26: Haas M, Meehan SM, Karrison TG et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from and Am J Kidney Dis 1997; 30: Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol 2003; 23: Korbet SM, Schwartz MM, Lewis EJ. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 1994; 23: Rydel JJ, Korbet SM, Borok RZ et al. Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis 1995; 25: Chun MJ, Korbet SM, Schwartz MM et al. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004; 15: Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 1998; 32: Korbet SM. Clinical picture and outcome of primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 1999; 14 (Suppl 3): Kazi JI, Mubarak M, Ahmed E et al. Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan. Clin Exp Nephrol 2009; 13: Cameron JS. Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant 2003; 18 (Suppl 6): vi45 vi Meyrier A. Nephrotic focal-segmental glomerulosclerosis in 2004: an update. Nephrol Dial Transplant 2004; 19: Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int 2002; 62: Banfi G, Moriggi M, Sabadini E et al. The impact of prolonged immunosuppression on the outcome of idiopathic focal segmental glomerulosclerosis. A collaborative retrospective study. Clin Nephrol 1991; 36: Matalon A, Valeri A, Appel GB. Treatment of focal segmental glomerulosclerosis. Semin Nephrol 2000; 20: Ponticelli C, Villa M, Banfi G et al. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis 1999; 34: Burgess E. Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int 1999; 55 (Suppl 70): S26 S Pei Y, Cattran D, Delmore T et al. Evidence suggesting undertreatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. Am J Med 1987; 82: Stirling CM. Focal segmental glomerulosclerosis-does treatment work? Nephron Clin Pract 2006; 104: c83 c Stirling CM, Mathieson P, Boulton-Jones JM et al. Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM 2005; 98: Goumenos DS, Tsagalis G, El Nahas AM et al. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five year follow up study. Nephron Clin Pract 2006; 104: c75 c Troyanov S, Wall CA, Miller JA et al. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol 2005; 16: Korbet SM, Schwartz MM. Primary focal segmental glomerulosclerosis: a treatable lesion with variable outcomes. Nephrology 2001; 6: Korbet SM. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Semin Nephrol 2003; 23: Geary DF, Farine M, Thorner P et al. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal. Clin Nephrol 1984; 22: Received for publication: ; Accepted in revised form:

Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients?

Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients? O R I G N A L A R T I C L E Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients? J.K.J. Deegens 1* K.J.M. Assmann 2, E.J. Steenbergen 2, L.B. Hilbrands 1, P.G.G.

More information

Steroid Resistant Nephrotic Syndrome. Sanjeev Gulati, Debashish Sengupta, Raj K. Sharma, Ajay Sharma, Ramesh K. Gupta*, Uttam Singh** and Amit Gupta

Steroid Resistant Nephrotic Syndrome. Sanjeev Gulati, Debashish Sengupta, Raj K. Sharma, Ajay Sharma, Ramesh K. Gupta*, Uttam Singh** and Amit Gupta Steroid Resistant Nephrotic Syndrome Sanjeev Gulati, Debashish Sengupta, Raj K. Sharma, Ajay Sharma, Ramesh K. Gupta*, Uttam Singh** and Amit Gupta From the Departments of Nephrology, Pathology* and Biostatistics**,

More information

Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective

Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective ORIGINAL ARTICLE Port J Nephrol Hypert 2016; 30(2): 127-133 Advance Access publication 24 April 2016 Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: Syed Abbas

More information

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome Pediatr Nephrol (2003) 18:833 837 DOI 10.1007/s00467-003-1175-4 BRIEF REPORT Gina-Marie Barletta William E. Smoyer Timothy E. Bunchman Joseph T. Flynn David B. Kershaw Use of mycophenolate mofetil in steroid-dependent

More information

Light and electron microscopical studies of focal glomerular sclerosis

Light and electron microscopical studies of focal glomerular sclerosis J. clin. Path., 1971, 24, 846-850 Light and electron microscopical studies of focal glomerular sclerosis A. H. NAGI, F. ALEXANDER, AND R. LANNIGAN From the Department of Pathology, Queen's University of

More information

Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population epidemiology and outcome

Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population epidemiology and outcome Nephrol Dial Transplant (2008) 23: 186 192 doi:10.1093/ndt/gfm523 Advance Access publication 17 August 2007 Original Article Pathological variants of focal segmental glomerulosclerosis in an adult Dutch

More information

Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants

Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants original article http://www.kidney-international.org & 2006 International Society of Nephrology Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants DB Thomas

More information

Glomerular Pathology- 1 Nephrotic Syndrome. Dr. Nisreen Abu Shahin

Glomerular Pathology- 1 Nephrotic Syndrome. Dr. Nisreen Abu Shahin Glomerular Pathology- 1 Nephrotic Syndrome Dr. Nisreen Abu Shahin The Nephrotic Syndrome a clinical complex resulting from glomerular disease & includes the following: (1) massive proteinuria (3.5 gm /day

More information

C1q nephropathy the Diverse Disease

C1q nephropathy the Diverse Disease C1q nephropathy the Diverse Disease Danica Galešić Ljubanović School of Medicine, University of Zagreb Dubrava University Hospital Zagreb, Croatia Definition Dominant or codominant ( 2+), mesangial staining

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of

More information

Management and Outcome of Steroid-Resistant Nephrotic Syndrome in Children

Management and Outcome of Steroid-Resistant Nephrotic Syndrome in Children kidney diseases Management and Outcome of Steroid-Resistant Nephrotic Syndrome in Children Hasan Otukesh, 1 Salman Otukesh, 2 Mona Mojtahedzadeh, 2 Rozita Hoseini, 1 Seyed-Mohammad Fereshtehnejad, 2 Azam

More information

Journal of Nephropathology

Journal of Nephropathology www.nephropathol.com DOI: 10.12860/jnp.2014.22 J Nephropathol. 2014; 3(3): 115-120 Journal of Nephropathology Clinicopathological correlations in lupus nephritis; a single center experience Hamid Nasri

More information

Immunoglobulin M Nephropathy in Adults A Clinicopathological Study

Immunoglobulin M Nephropathy in Adults A Clinicopathological Study Kidney Diseases Immunoglobulin M Nephropathy in Adults A Clinicopathological Study Muhammed Mubarak, 1 Rubina Naqvi, 2 Javed I Kazi, 1 Shaheera Shakeel 1 Original Paper 1 Histopathology Department, Sindh

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of steroid therapy GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of steroid therapy GUIDELINES Specific management of IgA nephropathy: role of steroid therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Steroid therapy may protect against progressive

More information

CHAPTER 2. Primary Glomerulonephritis

CHAPTER 2. Primary Glomerulonephritis 2nd Report of the PRIMARY GLOMERULONEPHRITIS CHAPTER 2 Primary Glomerulonephritis Sunita Bavanandan Lee Han Wei Lim Soo Kun 21 PRIMARY GLOMERULONEPHRITIS 2nd Report of the 2.1 Introduction This chapter

More information

CHAPTER 2 PRIMARY GLOMERULONEPHRITIS

CHAPTER 2 PRIMARY GLOMERULONEPHRITIS CHAPTER 2 Sunita Bavanandan Lim Soo Kun 19 5th Report of the 2.1: Introduction This chapter covers the main primary glomerulonephritis that were reported to the MRRB from the years 2005-2012. Minimal change

More information

Case Presentation Turki Al-Hussain, MD

Case Presentation Turki Al-Hussain, MD Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory

More information

Elevated Serum Creatinine, a simplified approach

Elevated Serum Creatinine, a simplified approach Elevated Serum Creatinine, a simplified approach Primary Care Update Creighton University School of Medicine. April 27 th, 2018 Disclosure Slide I have no disclosures and have no conflicts with this presentation.

More information

Clinicopathologic Characteristics of IgA Nephropathy with Steroid-responsive Nephrotic Syndrome

Clinicopathologic Characteristics of IgA Nephropathy with Steroid-responsive Nephrotic Syndrome J Korean Med Sci 2009; 24 (Suppl 1): S44-9 ISSN 1011-8934 DOI: 10.3346/jkms.2009.24.S1.S44 Copyright The Korean Academy of Medical Sciences Clinicopathologic Characteristics of IgA Nephropathy with Steroid-responsive

More information

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust Dr Ian Roberts Oxford Oxford Pathology Course 2010 for FRCPath Present the basic diagnostic features of the commonest conditions causing proteinuria & haematuria Highlight diagnostic pitfalls Nephrotic

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Membranous nephropathy Role of alkylating agents GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Membranous nephropathy Role of alkylating agents GUIDELINES Membranous nephropathy Role of alkylating agents Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES a. Treatment with alkylating agents is associated with an increased

More information

Case 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016

Case 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016 Case 3 Lynn D. Cornell, M.D. Mayo Clinic, Rochester, MN Cornell.Lynn@mayo.edu USCAP Renal Case Conference March 13, 2016 ACCME/Disclosure Dr. Cornell has nothing to disclose Clinical history 57-year-old

More information

FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS

FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS Guillermo A. Herrera MD Louisiana State University, Shreveport Fibrils in bundles 10-20 nm d Diabetic fibrillosis

More information

LONG-TERM OUTCOME OF PATIENTS WITH LUPUS NEPHRITIS: A SINGLE CENTER EXPERIENCE

LONG-TERM OUTCOME OF PATIENTS WITH LUPUS NEPHRITIS: A SINGLE CENTER EXPERIENCE & LONG-TERM OUTCOME OF PATIENTS WITH LUPUS NEPHRITIS: A SINGLE CENTER EXPERIENCE Senija Rašić 1 *, Amira Srna 1, Snežana Unčanin 1, Jasminka Džemidžić 1, Damir Rebić 1, Alma Muslimović 1, Maida Rakanović-Todić

More information

Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab

Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab TRANSPLANTATION Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab Khadijeh Makhdoomi, 1,2 Saeed Abkhiz, 1,2 Farahnaz Noroozinia, 1,3

More information

Dense deposit disease with steroid pulse therapy

Dense deposit disease with steroid pulse therapy Case Report Dense deposit disease with steroid pulse therapy Jun Odaka, Takahiro Kanai, Takane Ito, Takashi Saito, Jun Aoyagi, and Mariko Y Momoi Abstract Treatment of dense deposit disease DDD has not

More information

Nephrotic syndrome minimal change disease vs. IgA nephropathy. Hadar Meringer Internal medicine B Sheba

Nephrotic syndrome minimal change disease vs. IgA nephropathy. Hadar Meringer Internal medicine B Sheba Nephrotic syndrome minimal change disease vs. IgA nephropathy Hadar Meringer Internal medicine B Sheba The Case 29 year old man diagnosed with nephrotic syndrome 2 weeks ago and complaining now about Lt.flank

More information

THE URINARY SYSTEM. The cases we will cover are:

THE URINARY SYSTEM. The cases we will cover are: THE URINARY SYSTEM The focus of this week s lab will be pathology of the urinary system. Diseases of the kidney can be broken down into diseases that affect the glomeruli, tubules, interstitium, and blood

More information

THE URINARY SYSTEM. The cases we will cover are:

THE URINARY SYSTEM. The cases we will cover are: THE URINARY SYSTEM The focus of this week s lab will be pathology of the urinary system. Diseases of the kidney can be broken down into diseases that affect the glomeruli, tubules, interstitium, and blood

More information

Chapter 4: Steroid-resistant nephrotic syndrome in children Kidney International Supplements (2012) 2, ; doi: /kisup.2012.

Chapter 4: Steroid-resistant nephrotic syndrome in children Kidney International Supplements (2012) 2, ; doi: /kisup.2012. http://www.kidney-international.org & 2012 KDIGO Chapter 4: Steroid-resistant nephrotic syndrome in children Kidney International Supplements (2012) 2, 172 176; doi:10.1038/kisup.2012.17 INTRODUCTION This

More information

Pattern of biopsy proven renal diseases at PNS SHIFA, Karachi: A cross-sectional survey

Pattern of biopsy proven renal diseases at PNS SHIFA, Karachi: A cross-sectional survey J Renal Inj Prev. 2013; 2(4): 133-137. DOI: 10.12861/jrip.2013.43 Journal of Renal Injury Prevention Pattern of biopsy proven renal diseases at PNS SHIFA, Karachi: A cross-sectional survey Sohail Sabir

More information

Out of date SUGGESTIONS FOR CLINICAL CARE (Suggestions are based on level III and IV evidence)

Out of date SUGGESTIONS FOR CLINICAL CARE (Suggestions are based on level III and IV evidence) Membranous nephropathy role of cyclosporine therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES a. The use of cyclosporine therapy alone to prevent progressive

More information

Pattern of Glomerular Diseases in Gombe, Northeastern Nigeria

Pattern of Glomerular Diseases in Gombe, Northeastern Nigeria SHORT COMMUNICATION Pattern of Glomerular Diseases in Gombe, Northeastern Nigeria 1 2 1 2 2 1 3 Sulaiman MM, Lawan AI, Bakki B, Abdullahi YM, Aliyu UB, Sanni IO, Ummate I, 4 5 6 Usman AU, Shettima J, Pindiga

More information

Nephrotic Syndrome NS

Nephrotic Syndrome NS Nephrotic Syndrome NS By : Dr. Iman.M. Mudawi Pediatric Nephrology Unit Gaafar Ibn Auf Hospital Definitions: In children NS is applied to any condition with a triad of: Heavy proteinuria (UACR ratio >200

More information

Special Challenges and Co-Morbidities

Special Challenges and Co-Morbidities Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine

More information

Interesting case seminar: Native kidneys Case Report:

Interesting case seminar: Native kidneys Case Report: Interesting case seminar: Native kidneys Case Report: Proximal tubulopathy and light chain deposition disease presented as severe pulmonary hypertension with right-sided cardiac dysfunction and nephrotic

More information

Paediatrics Dr. Bakr Lecture 3 Nephrotic Syndrome

Paediatrics Dr. Bakr Lecture 3 Nephrotic Syndrome P a g e 1 DEFINITION Paediatrics Dr. Bakr Lecture 3 Nephrotic Syndrome Definition: nephrotic syndrome is a disorder characterized by heavy proteinuria with hypoprpteinimia,hyper lipidemia and edema. It

More information

Evaluation and Management of Proteinuria. Negiin Pourafshar, MD University of Virginia Division of Nephrology

Evaluation and Management of Proteinuria. Negiin Pourafshar, MD University of Virginia Division of Nephrology Evaluation and Management of Proteinuria Negiin Pourafshar, MD University of Virginia Division of Nephrology Case A 30-year-old man, is turned down for life insurance because of the presence of an unspecified

More information

Original. IgAN. Key words : IgA nephropathy, IgM deposition, proteinuria, tonsillectomy, steroid pulse therapy. Introduction

Original. IgAN. Key words : IgA nephropathy, IgM deposition, proteinuria, tonsillectomy, steroid pulse therapy. Introduction Showa Univ J Med Sci 27 3, 167 174, September 2015 Original Prominent IgM Deposition in Glomerulus Is Associated with Severe Proteinuria and Reduced after Combined Treatment of Tonsillectomy with Steroid

More information

RENAL HISTOPATHOLOGY

RENAL HISTOPATHOLOGY RENAL HISTOPATHOLOGY Peter McCue, M.D. Department of Pathology, Anatomy & Cell Biology Sidney Kimmel Medical College There are no conflicts of interest. 1 Goals and Objectives! Goals Provide introduction

More information

Glomerular tip adhesions predict the progression of IgA nephropathy

Glomerular tip adhesions predict the progression of IgA nephropathy Maeda et al. BMC Nephrology 2013, 14:272 RESEARCH ARTICLE Open Access Glomerular tip adhesions predict the progression of IgA nephropathy Kunihiro Maeda 1, Shogo Kikuchi 2, Naoto Miura 1, Keisuke Suzuki

More information

Case Presentation Turki Al-Hussain, MD

Case Presentation Turki Al-Hussain, MD Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory

More information

Surgical Pathology Report

Surgical Pathology Report Louisiana State University Health Sciences Center Department of Pathology Shreveport, Louisiana Accession #: Collected: Received: Reported: 6/1/2012 09:18 6/2/2012 09:02 6/2/2012 Patient Name: Med. Rec.

More information

RENAL EVENING SPECIALTY CONFERENCE

RENAL EVENING SPECIALTY CONFERENCE RENAL EVENING SPECIALTY CONFERENCE Harsharan K. Singh, MD The University of North Carolina at Chapel Hill Disclosure of Relevant Financial Relationships No conflicts of interest to disclose. CLINICAL HISTORY

More information

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 71/ Sept 03, 2015 Page 12361

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 71/ Sept 03, 2015 Page 12361 CLINICAL, BIOCHEMICAL AND HISTOPATHOLOGICAL PROFILE OF ADULT NEPHROTIC SYNDROME PATIENTS IN A TERTIARY CARE HOSPITAL S. Krishnamoorthy 1, S. R. Ramakrishnan 2, Bavya Vivek 3, L. Suja 4 HOW TO CITE THIS

More information

Improved outcomes in nephrotic syndrome

Improved outcomes in nephrotic syndrome MEDICAL GRAND ROUNDS CME CREDIT GERALD B. APPEL, MD * Director of Clinical Nephrology and Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, NY TAKE-HOME

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Idiopathic membranous nephropathy: use of other therapies GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. Idiopathic membranous nephropathy: use of other therapies GUIDELINES Idiopathic membranous nephropathy: use of other therapies Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES No recommendations possible based on Level I or II evidence

More information

THE KIDNEY AND SLE LUPUS NEPHRITIS

THE KIDNEY AND SLE LUPUS NEPHRITIS THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS

More information

Treatment of MGN A roundtable discussion based on best evidence Drs Cattran Expert Panel Dr Ruggenenti,Falk,Ponticelli,Fervenza,Remuzzi

Treatment of MGN A roundtable discussion based on best evidence Drs Cattran Expert Panel Dr Ruggenenti,Falk,Ponticelli,Fervenza,Remuzzi Treatment of MGN A roundtable discussion based on best evidence Drs Cattran Expert Panel Dr Ruggenenti,Falk,Ponticelli,Fervenza,Remuzzi Level 1 2 3 4 5 6 Definition of evidence Randomized, controlled trial

More information

N. Hiramatsu, T. Kuroiwa, H. Ikeuchi, A. Maeshima, Y. Kaneko, K. Hiromura, K. Ueki and Y. Nojima

N. Hiramatsu, T. Kuroiwa, H. Ikeuchi, A. Maeshima, Y. Kaneko, K. Hiromura, K. Ueki and Y. Nojima Rheumatology 28;47:72 77 Advance Access publication 4 April 28 doi:1.193/rheumatology/ken19 Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion

More information

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA

More information

An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy?

An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy? CEN Case Rep (2015) 4:70 75 DOI 10.1007/s13730-014-0142-1 CASE REPORT An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy? Hironari

More information

Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy

Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy Nephrol Dial Transplant (2011) 26: 1570 1575 doi: 10.1093/ndt/gfq559 Advance Access publication 14 September 2010 Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy Seung Hyeok

More information

Can We Predict Relapses in Children with Idiopathic Steroid-Sensitive Nephrotic Syndrome?

Can We Predict Relapses in Children with Idiopathic Steroid-Sensitive Nephrotic Syndrome? JOURNAL OF TROPICAL PEDIATRICS, VOL. 59, NO. 5, 2013 Can We Predict Relapses in Children with Idiopathic Steroid-Sensitive Nephrotic Syndrome? by Om P. Mishra, 1 Abhishek Abhinay, 1 Rabindra N. Mishra,

More information

Cellular focal segmental glomerulosclerosis: Clinical and pathologic features

Cellular focal segmental glomerulosclerosis: Clinical and pathologic features http://www.kidney-international.org & 2006 International Society of Nephrology original article see commentary on page 1676 Cellular focal segmental glomerulosclerosis: Clinical and pathologic features

More information

A clinical syndrome, composed mainly of:

A clinical syndrome, composed mainly of: Nephritic syndrome We will discuss: 1)Nephritic syndrome: -Acute postinfectious (poststreptococcal) GN -IgA nephropathy -Hereditary nephritis 2)Rapidly progressive GN (RPGN) A clinical syndrome, composed

More information

Ordering Physician. Collected REVISED REPORT. Performed. IgG IF, Renal MCR. Lambda IF, Renal MCR. C1q IF, Renal. MCR Albumin IF, Renal MCR

Ordering Physician. Collected REVISED REPORT. Performed. IgG IF, Renal MCR. Lambda IF, Renal MCR. C1q IF, Renal. MCR Albumin IF, Renal MCR RenalPath Level IV Wet Ts IgA I Renal IgM I Renal Kappa I Renal Renal Bx Electron Microscopy IgG I Renal Lambda I Renal C1q I Renal C3 I Renal Albumin I Renal ibrinogen I Renal Mayo Clinic Dept. of Lab

More information

Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease

Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease KIDNEY DISEASES Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease Heba Mostafa Ahmed, 1 Dina Ahmed Ezzat, 1 Noha A Doudar, 2 Mai Adel 1 1 Departement of Pediatrics,

More information

Dual positive serology in a case of rapidly progressive glomerulonephritis in a middle aged woman

Dual positive serology in a case of rapidly progressive glomerulonephritis in a middle aged woman CASE REPORT Advance Access publication 20 May 2014 Dual positive serology in a case of rapidly progressive glomerulonephritis in a middle aged woman Rubina Naqvi 1, Muhammed Mubarak 2 1 Department of Nephrology

More information

16.1 Risk of UTI recurrence in children

16.1 Risk of UTI recurrence in children 16. UTI prognosis 16.1 Risk of UTI recurrence in children Key question: What is the risk of recurrent UTI in children with no known structural or functional abnormalities of the urinary tract with a first

More information

Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis

Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis http://www.kidney-international.org & 213 International Society of Nephrology see commentary on page 235 Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary

More information

Mr. I.K 58 years old

Mr. I.K 58 years old Mr. I.K 58 years old Hospitalized because of marked pitting peripheral edema (bilateral crural and perimalleolar edema) and uncontrolled blood pressure (BP 150/100 mmhg under treatment). since age 54 years

More information

Additional file 2: Details of cohort studies and randomised trials

Additional file 2: Details of cohort studies and randomised trials Reference Randomised trials Ye et al. 2001 Abstract 274 R=1 WD=0 Design, numbers, treatments, duration Randomised open comparison of: (45 patients) 1.5 g for 3, 1 g for 3, then 0.5 to 0.75 g IV cyclophosphamide

More information

Nephrotic syndrome in children. Bashir Admani KPA Nephrology Precongress 24/4/2018

Nephrotic syndrome in children. Bashir Admani KPA Nephrology Precongress 24/4/2018 Nephrotic syndrome in children Bashir Admani KPA Nephrology Precongress 24/4/2018 What is Nephrotic syndrome?? Nephrotic syndrome is caused by renal diseases that increase the permeability across the glomerular

More information

Prediction of relapses in children with idiopathic steroid sensitive nephrotic syndrome: a retrospective study

Prediction of relapses in children with idiopathic steroid sensitive nephrotic syndrome: a retrospective study International Journal of Contemporary Pediatrics Prasun B. et al. Int J Contemp Pediatr. 2017 Jan;4(1):xxx-xxx http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Original Research Article DOI:

More information

Ανάπτυξη Βιοτράπεζας για την Ανίχνευση Πρώιμων Βιοδεικτών σε Ασθενείς με Χρόνια Νεφρική Νόσο

Ανάπτυξη Βιοτράπεζας για την Ανίχνευση Πρώιμων Βιοδεικτών σε Ασθενείς με Χρόνια Νεφρική Νόσο Ανάπτυξη Βιοτράπεζας για την Ανίχνευση Πρώιμων Βιοδεικτών σε Ασθενείς με Χρόνια Νεφρική Νόσο ΔΗΜΗΤΡΙΟΣ Σ. ΓΟΥΜΕΝΟΣ Νεφρολογικό και Μεταμοσχευτικό Κέντρο Πανεπιστημιακό Νοσοκομείο Πατρών Causes of chronic

More information

Atypical IgA Nephropathy

Atypical IgA Nephropathy Atypical IgA Nephropathy Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA XXXIII Chilean Congress of Nephrology, Hypertension and Transplantation Puerto Varas, Chile October 6, 2016 IgA

More information

Renal Data from the Arab World

Renal Data from the Arab World Saudi J Kidney Dis Transpl 2013;24(2):387-391 2013 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Renal Data from the Arab World Pattern of Glomerular Diseases

More information

Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy

Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy M.X. Li, Y.W. Yu, Z.Y. Zhang, H.D. Zhao and F.L. Xiao Department of Nephrology, The Navy

More information

The CARI Guidelines Caring for Australasians with Renal Impairment

The CARI Guidelines Caring for Australasians with Renal Impairment Specific management of IgA nephropathy: role of triple therapy and cytotoxic therapy Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES a. Triple therapy with cyclophosphamide,

More information

Membranous nephropathy. By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University

Membranous nephropathy. By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University Membranous nephropathy By Mohammed Kamal Nassar, MD Lecturer of Nephrology Mansoura University Membranous nephropathy Definition: Immune complex glomerular disease in which immune deposits of IgG and complement

More information

Original Article. Renal diseases in the elderly underwent to percutaneous biopsy of native kidneys. Introduction

Original Article. Renal diseases in the elderly underwent to percutaneous biopsy of native kidneys. Introduction Original Article Renal diseases in the elderly underwent to percutaneous biopsy of native kidneys Authors Claudine Maria Jorge de Oliveira 1 Roberto Silva Costa 2 Osvaldo Merege Vieira Neto 3 Rosana Aparecida

More information

Renal Biopsy Findings in Children Receiving Long-Term Treatment with Cyclosporine A Given as a Single Daily Dose

Renal Biopsy Findings in Children Receiving Long-Term Treatment with Cyclosporine A Given as a Single Daily Dose Tohoku J. Exp. Med., Posttreatment 2006, 209, 191-196 Renal Biopsy Following Once-daily CsA Treatment 191 Renal Biopsy Findings in Children Receiving Long-Term Treatment with Cyclosporine A Given as a

More information

Secondary IgA Nephropathy & HSP

Secondary IgA Nephropathy & HSP Secondary IgA Nephropathy & HSP Anjali Gupta, MD 1/11/11 AKI sec to Hematuria? 65 cases of ARF after an episode of macroscopic hematuria have been reported in the literature in patients with GN. The main

More information

Practice Patterns and Outcomes of ACTHar use in Children with Nephrotic Syndrome

Practice Patterns and Outcomes of ACTHar use in Children with Nephrotic Syndrome Page 1 of 16 Practice Patterns and Outcomes of ACTHar use in Children with Nephrotic Syndrome MANUAL OF OPERATIONS VERSION 1.0 March 10, 2016 Page 2 of 16 STUDY PERSONNEL CONTACT INFORMATION Principal

More information

Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome

Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome Nephrol Dial Transplant (2005) 20: 2243 2247 doi:10.1093/ndt/gfh996 Advance Access publication 19 July 2005 Brief Report Oral mizoribine pulse therapy for patients with steroid-resistant and frequently

More information

Nephrology Grand Rounds. Mansi Mehta November 24, 2015

Nephrology Grand Rounds. Mansi Mehta November 24, 2015 Nephrology Grand Rounds Mansi Mehta November 24, 2015 Case 51yo F with PMH significant for Hypertension referred to renal clinic for evaluation of elevated Cr. no known history of CKD; baseline creatinine

More information

Dr Michael Rayment Chelsea and Westminster Hospital, London

Dr Michael Rayment Chelsea and Westminster Hospital, London 17 TH ANNUAL CONFERENCE OF THE BRITISH HIV ASSOCIATION (BHIVA) Dr Michael Rayment Chelsea and Westminster Hospital, London 6-8 April 2011, Bournemouth International Centre A decade of renal biopsies in

More information

Article. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS

Article. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS Article Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS Louis-Philippe Laurin,* Adil M. Gasim, Caroline J. Poulton, Susan L. Hogan, J. Charles Jennette, Ronald J. Falk, Bethany

More information

Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults Kidney International Supplements (2012) 2, ; doi: /kisup.2012.

Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults Kidney International Supplements (2012) 2, ; doi: /kisup.2012. http://www.kidney-international.org chapter 6 & 2012 KDIGO Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults Kidney International Supplements (2012) 2, 181 185; doi:10.1038/kisup.2012.19

More information

Journal of Nephropathology

Journal of Nephropathology www.nephropathol.com DOI: 10.12860/jnp.2015.04 J Nephropathol. 2015; 4(1): 19-23 Journal of Nephropathology Association of glomerular C4d deposition with various demographic data in IgA nephropathy patients;

More information

Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses

Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses Nephrol Dial Transplant (2003) 18: 1316 1320 DOI: 10.1093/ndt/gfg134 Original Article Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses Kai-Chung

More information

CASE OF THE WEEK 1

CASE OF THE WEEK 1 www.nephro-pathology.com CASE OF THE WEEK 1 Clinical Presentation: A 17 year old Indian boy presented with anasarca, decreased urine output and episodes of nausea and vomiting over the last three weeks.

More information

Monoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH

Monoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH Monoclonal Gammopathies and the Kidney Tibor Nádasdy, MD The Ohio State University, Columbus, OH Monoclonal gammopathy of renal significance (MGRS) Biopsies at OSU (n=475) between 2007 and 2016 AL or AH

More information

Prof. Rosanna Coppo Director of the Nephrology, Dialysis and Transplantation Department Regina Margherita Hospital Turin, Italy. Slide 1.

Prof. Rosanna Coppo Director of the Nephrology, Dialysis and Transplantation Department Regina Margherita Hospital Turin, Italy. Slide 1. ROLE OF PATHOLOGY AND CLINICAL FEATURES IN PREDICTING PROGRESSION OF IGA NEPHROPATHY: RESULTS FROM THE ERA-EDTA RESEARCH VALIGA Rosanna Coppo, Turin, Italy Chairs: François Berthoux, Saint-Etienne, France

More information

The natural history of immunoglobulin M nephropathy in adults

The natural history of immunoglobulin M nephropathy in adults Nephrol Dial Transplant (2017) 32: 823 829 doi: 10.1093/ndt/gfw063 Advance Access publication 15 April 2016 The natural history of immunoglobulin M nephropathy in adults Thomas M. Connor 1, Valeria Aiello

More information

Classification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus

Classification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus Classification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus Mark Haas MD, PhD Department of Pathology & Laboratory Medicine Cedars-Sinai Medical

More information

Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations

Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations Clin Kidney J (2014) 7: 531 537 doi: 10.1093/ckj/sfu100 Advance Access publication 28 September 2014 Original Article Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations Sanjeev

More information

Case Report Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage

Case Report Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage Case Reports in Nephrology Volume, Article ID 89, pages doi:.//89 Case Report Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage Claudio Pozzi, Francesca Ferrario, Bianca

More information

Treatment Aspects of Primary Nephrotic Syndrome in Adults

Treatment Aspects of Primary Nephrotic Syndrome in Adults & Treatment Aspects of Primary Nephrotic Syndrome in Adults Senija Rašić*¹, Snježana Unčanin¹, Jasminka Džemidžić¹, Kenana Aganović¹, Amira Srna¹, Ismar Rašić² 1. Institute for Nephrology, Clinical Centre

More information

Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy

Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy Author's response to reviews Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy Authors: Nan Zhen Dong (dongzn@301hospital.com.cn) Yong

More information

SPECTRUM OF GLOMERULAR DISEASES: AN 11 YEAR RETROSPECTIVE REVIEW IN A TERTIARY CARE HOSPITAL IN PAKISTAN.

SPECTRUM OF GLOMERULAR DISEASES: AN 11 YEAR RETROSPECTIVE REVIEW IN A TERTIARY CARE HOSPITAL IN PAKISTAN. Original Article AN 11 YEAR RETROSPECTIVE REVIEW IN A TERTIARY CARE HOSPITAL IN PAKISTAN. * * * Naila Asif, Kunwer Naveed Mukhtar, Farzana Adnan * Assistant Professor, Consultant Nephrologist, Department

More information

IgA Nephropathy - «Maladie de Berger»

IgA Nephropathy - «Maladie de Berger» IgA Nephropathy - «Maladie de Berger» B. Vogt, Division de Néphrologie/Consultation d Hypertension CHUV, Lausanne 2011 Montreux CME SGN-SSN IgA Nephropathy 1. Introduction 2. Etiology and Pathogenesis

More information

Focal Segmental Glomerulosclerosis and the Nephro6c Syndrome Dr. A. Gangji Dr. P. Marge>s. Part 1: Clinical

Focal Segmental Glomerulosclerosis and the Nephro6c Syndrome Dr. A. Gangji Dr. P. Marge>s. Part 1: Clinical Focal Segmental Glomerulosclerosis and the Nephro6c Syndrome Dr. A. Gangji Dr. P. Marge>s Part 1: Clinical Pa#ent DM 18 year old McMaster student Back pain, severe fa#gue Oct 2006 Leg swelling to ER Nov

More information

Accepted Manuscript. Glomerulopathy Associated with Moderate Obesity

Accepted Manuscript. Glomerulopathy Associated with Moderate Obesity Accepted Manuscript Glomerulopathy Associated with Moderate Obesity Yusuke Okabayashi, M.D., Nobuo Tsuboi, M.D. Ph.D., Takaya Sasaki, M.D., Kotaro Haruhara, M.D., Go Kanzaki, M.D., Kentaro Koike, M.D.

More information

A Randomized Controlled Trial of Intravenous Vs Oral Cyclophosphamide in Steroid Resistant Nephrotic Syndrome

A Randomized Controlled Trial of Intravenous Vs Oral Cyclophosphamide in Steroid Resistant Nephrotic Syndrome Original article A Randomized Controlled Trial of Intravenous Vs Oral Cyclophosphamide in Steroid Resistant Nephrotic Syndrome Alpana Ohri 1, Kronal Shah 2, Uma Ali 3 1Associate Professor, 2 Jr. Registrar,

More information

STEROID-RESISTANT NEPHROTIC SYNDROME (SRNS)

STEROID-RESISTANT NEPHROTIC SYNDROME (SRNS) MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH CLINICAL RESEARCH CENTRE FOR RARE DISEASES ALDO E CELE DACCO' Villa Camozzi - 24020 Ranica (Bergamo) Italy Telephone 39-35-4535304 fax 39-35-4535373 STEROID-RESISTANT

More information

Primary Glomerulonephritides

Primary Glomerulonephritides Primary Glomerulonephritides Idiopathic Nephrotic Syndrome in Adults Stephen M. Korbet, M.D. Rush University Medical Center Chicago, Illinois 40% 35% 30% 34% 35% 33% 33% Korbet Haas 25% 20% 15% 10% 5%

More information

Pathology of Complement Mediated Renal Disease

Pathology of Complement Mediated Renal Disease Pathology of Complement Mediated Renal Disease Mariam Priya Alexander, MD Associate Professor of Pathology GN Symposium Hong Kong Society of Nephrology July 8 th, 2017 2017 MFMER slide-1 The complement

More information

Proteinuria. Louisiana State University

Proteinuria. Louisiana State University Proteinuria W S A V A W C P, 2005 David F. Senior Louisiana State University The normal glomerulus is a highly selective barrier for filtration based on size (and on charge in the case of larger molecules).

More information